InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（6 笔）
内部人交易记录
首席财务官已披露买入
2
已披露卖出
6
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Lucera Erick, 首席财务官. Insider active across 3 companies, notably Dyne Therapeutics, Inc.. Aggregated, 12 reports have been published. Breakdown: 2 buys · 6 sells. Total volume traded: €305k. History available since 16 March 2023. The latest transaction was filed on 13 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Lucera Erick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
1,797 股@ US$26.280.0010% mcap17.1% 占其流量Common StockSEC:0001697616-26-000002:0
2,362 股Common StockSEC:0001193125-26-285505:0
1,448 股@ US$18.360.0005% mcap50.0% 占其流量Common StockSEC:0001193125-26-223961:0
5,727 股@ US$18.6467.0% 占其流量Common StockSEC:0001193125-26-142137:0
65,000 股0Common StockSEC:0001193125-26-055052:0
66,100 股0Common StockSEC:0000950170-25-048601:0
4,109 股@ US$1.71085.5% 占其流量Common StockSEC:0001650664-25-000027:0
39,266 股@ US$0.396452.3% 占其流量Common StockSEC:0001493152-24-032675:0
标准退出：2024年11月12日 (T+90)
22,337 股@ US$5.614294.5% 占其流量Common StockSEC:0001650664-24-000044:0
35,300 股0Common StockSEC:0001650664-24-000019:0
77,900 股0Common StockSEC:0001415889-23-008293:0
2,000 股@ US$6.81747.7% 占其流量Common StockSEC:0001493152-23-008245:0
标准退出：2023年6月14日 (T+90)
12 条申报中的 12 条
About Lucera Erick
Lucera Erick is Chief Financial Officer and appears in 11 filings. Across the 11 sampled filings, from 2023-03-20 to 2026-06-26, purchases amount to EUR 27016 and sales to EUR 236962, with Cession as the modal transaction nature. The largest filings concern Editas Medicine, Inc., Dyne Therapeutics, Inc. and Beyond Air, Inc.
